ZYMEWORKS ($ZYME) posted quarterly earnings results on Wednesday, March 5th. The company reported earnings of -$0.31 per share, missing estimates of -$0.10 by $0.21. The company also reported revenue of $31,030,000, missing estimates of $46,104,295 by $-15,074,295.
You can see Quiver Quantitative's $ZYME stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ZYMEWORKS Insider Trading Activity
ZYMEWORKS insiders have traded $ZYME stock on the open market 18 times in the past 6 months. Of those trades, 13 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ZYME stock by insiders over the last 6 months:
- CAPITAL, LLC ECOR1 has made 13 purchases buying 1,027,880 shares for an estimated $14,420,459 and 0 sales.
- KENNETH GALBRAITH (Chair & CEO) has made 0 purchases and 2 sales selling 57,291 shares for an estimated $855,016.
- PAUL ANDREW MOORE (Chief Scientific Officer) has made 0 purchases and 2 sales selling 21,200 shares for an estimated $316,390.
- JEFFREY T L SMITH (EVP & Chief Medical Officer) sold 11,110 shares for an estimated $165,806
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ZYMEWORKS Hedge Fund Activity
We have seen 70 institutional investors add shares of ZYMEWORKS stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ECOR1 CAPITAL, LLC added 1,590,606 shares (+11.8%) to their portfolio in Q4 2024, for an estimated $23,286,471
- MORGAN STANLEY removed 905,432 shares (-17.7%) from their portfolio in Q4 2024, for an estimated $13,255,524
- BLACKSTONE INC. added 544,633 shares (+2171.4%) to their portfolio in Q4 2024, for an estimated $7,973,427
- SIO CAPITAL MANAGEMENT, LLC removed 491,128 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $6,163,656
- WALLEYE CAPITAL LLC added 452,804 shares (+inf%) to their portfolio in Q4 2024, for an estimated $6,629,050
- VESTAL POINT CAPITAL, LP removed 430,000 shares (-69.9%) from their portfolio in Q4 2024, for an estimated $6,295,200
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 407,771 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $5,969,767
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
